CDC Signs Off on RSV Vaccine for Older Adults

The CDC gave a green light to two new vaccines to protect against respiratory syncytial virus, or RSV, in older adults. CDC Director Rochelle P. Walensky, MD, MPH, agreed with and endorsed the recommendations made by CDC advisors that people aged 60 and over may get one of two new vaccines for RSV. The new vaccines, the first licensed in the U.S. to protect against the respiratory illness, are expected to be available this fall.

Link: Medscape Medical News (6/2023)